Fatigue News and Research

RSS

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

Pfizer Inc. announced today that top-line results for Lyrica Study A0081107 - Central Neuropathic Pain Following Spinal Cord Injury - demonstrated that the study met its primary endpoint: positive efficacy in reducing Central Neuropathic Pain following Spinal Cord Injury with Lyrica compared to placebo.

22 Jun 2011

Tips for protecting your skin from sun's harmful rays

Summer is here and for many that means enjoying more outdoor activities. While it's important to remember sun safety, from time-to-time sunburns are bound to happen. Covenant Health System would like to promote sun safety and offer some useful remedies for dealing with sunburns.

22 Jun 2011

Blood-alcohol levels well below the U.S. legal limit linked to incapacitating injury, death

In the United States, the blood-alcohol limit may be 0.08 percent, but no amount of alcohol seems to be safe for driving, according to a University of California, San Diego sociologist. A study led by David Phillips and published in the journal Addiction finds that blood-alcohol levels well below the U.S. legal limit are associated with incapacitating injury and death.

21 Jun 2011

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Genentech, a member of the Roche Group, announced today that a pivotal Phase II study with vismodegib showed positive results in people with advanced basal cell carcinoma (BCC) for whom surgery is considered inappropriate.

20 Jun 2011

Short warm-ups permit greater cycling performance

Coaches, physiologists and athletes alike will attest to the importance of warming up before athletic competition. Warming up increases muscle temperature, accelerates oxygen uptake kinetics and increases anaerobic metabolism, all of which enhance performance.

18 Jun 2011

Boiron launches new natural and non-steroidal products for athletes to treat muscle pain

Boiron Canada launches Arnicare Sport, a brand new product designed for athletes, whether professional, amateur or recreational. Arnicare Sport makes physical activity pleasant by preventing and reducing cramps, aches and muscular fatigue.

14 Jun 2011

Perceived racism linked to elevated risk of self-reported sleep disturbance

Perceived racial discrimination is associated with an increased risk of sleep disturbance, which may have a negative impact on mental and physical health, suggests a research abstract that will be presented Tuesday, June 14, in Minneapolis, Minn., at SLEEP 2011, the 25th Anniversary Meeting of the Associated Professional Sleep Societies LLC.

14 Jun 2011

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Ambit Biosciences Corporation and Astellas Pharma Inc. announced today results from a planned interim analysis in an ongoing Phase 2 study evaluating AC220, a potent and selective FLT3 inhibitor.

14 Jun 2011

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that preliminary results from its ENABLE Phase 2 proof-of-concept trial demonstrated that bafetinib, the Company's Bcr-Abl, Lyn and Fyn kinase inhibitor, was clinically active in a group of patients with relapsed or refractory B-cell chronic lymphocytic leukemia (B-CLL) who have failed several other treatments for their cancer.

13 Jun 2011

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

Alexion Pharmaceuticals, Inc. today announced the presentation of research that provides further insight into the clinical consequences of paroxysmal nocturnal hemoglobinuria (PNH), and positive impact of Soliris® (eculizumab) therapy on long-term outcomes.

13 Jun 2011

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

Valeant Pharmaceuticals International, Inc. and GlaxoSmithKline announced today that the U.S. Food and Drug Administration (FDA) has approved Potiga Tablets, a potassium channel opener, as adjunctive treatment of partial-onset seizures in patients aged 18 years and older.

13 Jun 2011

Seattle Genetics, Millennium ADCETRIS phase I trial data on Hodgkin lymphoma presented at EHA

Millennium: The Takeda Oncology Company, a wholly owned subsidiary of Takeda Pharmaceutical Company Limited and Seattle Genetics, Inc., announced today that data on ADCETRIS (brentuximab vedotin) in relapsed or refractory Hodgkin lymphoma patients were featured in an oral presentation at the 16th Congress of the European Hematology Association (EHA) in London.

13 Jun 2011

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

Data to be presented tomorrow at the 16th Annual Meeting of the European Hematology Association (EHA) in London, UK, show that Micromet's blinatumomab produced a high complete remission rate in adult patients with acute lymphoblastic leukemia (ALL) who had relapsed following treatment with standard therapy.

10 Jun 2011

Tips for pregnant women during summer

Hot, humid and pregnant. Many women would call that a recipe for misery. But UAB obstetrician Kim Hoover, M.D., says there are real medical conditions that pregnant women should guard against to stay safe and healthy as the temperature rises.

10 Jun 2011

Toxin known to affect humans identified in endangered Hawaiian monk seal

Researchers from NOAA have discovered a potent and highly-debilitating toxin in the endangered Hawaiian monk seal, a first-of-its-kind chemical finding that is now prompting investigations of other marine mammals in the state.

9 Jun 2011

Cabozantinib shows early promise in treatment of prostate cancer spread to the bone

A new drug to treat prostate cancer shows early promise, particularly against tumors that have spread to the bone, a multi-site study shows.

8 Jun 2011

Age does not affect testosterone level in healthy older men

A decline in testosterone levels as men grow older is likely the result—not the cause—of deteriorating general health, say Australian scientists, whose new study finds that age, in itself, has no effect on testosterone level in healthy older men.

8 Jun 2011

ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011

Celgene International Sàrl today announced that results from two investigator initiated studies including ABRAXANE, and bevacizumab in unresectable melanoma were presented at the 2011 American Society of Clinical Oncology Annual Meeting in Chicago, IL.

7 Jun 2011

Agilent Technologies introduces mass spectrometry systems at ASMS 2011

Agilent Technologies Inc. today introduced mass spectrometry systems raising performance standards for biology and analytical chemistry analyses at the annual conference of the American Society of Mass Spectrometry.

7 Jun 2011

Synta presents ganetespib Phase 1, 2 trial results against solid tumors at ASCO 2011

Synta Pharmaceuticals Corp. today presented results at the Annual Meeting of the American Society for Clinical Oncology (ASCO) from a Phase 2 single agent clinical trial of ganetespib in gastrointestinal stromal tumors (GIST) and a Phase 1 trial of ganetespib in solid tumors evaluating a twice-weekly administration schedule.

7 Jun 2011

Fatigue News and Research

Pfizer Lyrica Phase 3 study on Central Neuropathic Pain meets primary endpoint

Tips for protecting your skin from sun's harmful rays

Blood-alcohol levels well below the U.S. legal limit linked to incapacitating injury, death

Positive results from vismodegib Phase II study on advanced basal cell carcinoma

Short warm-ups permit greater cycling performance

Boiron launches new natural and non-steroidal products for athletes to treat muscle pain

Perceived racism linked to elevated risk of self-reported sleep disturbance

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

Study reveals positive impact of Soliris on long-term outcomes in PNH patients

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

Seattle Genetics, Millennium ADCETRIS phase I trial data on Hodgkin lymphoma presented at EHA

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

Tips for pregnant women during summer

Toxin known to affect humans identified in endangered Hawaiian monk seal

Cabozantinib shows early promise in treatment of prostate cancer spread to the bone

Age does not affect testosterone level in healthy older men

ABRAXANE and bevacizumab clinical studies on unresectable melanoma presented at ASCO 2011

Agilent Technologies introduces mass spectrometry systems at ASMS 2011

Synta presents ganetespib Phase 1, 2 trial results against solid tumors at ASCO 2011

Industry Focus eBook - Analytical Chemistry (2nd Edition) eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News